Libya Eliminates Trachoma, Ending Century of Blindness

A disease that has caused blindness in Libya for over a century is finally gone, marking a historic win for public health in one of the world's most challenging regions.

The World Health Organization announced this week that Libya has eliminated trachoma as a public health problem. This means future generations of Libyan children will never suffer from a bacterial infection that scars the inner eyelid, turns eyelashes inward to scratch the eyeball, and can lead to permanent blindness.

The achievement is especially remarkable because Libya accomplished it during years of political turmoil, population displacement, and strained health services. While many countries pause public health programs during crises, Libya's health workers pushed forward, reaching every district to deliver eye care and conduct surveys.

Trachoma spreads through contact with infected eye discharge on hands, clothing, or flies. In the 20th century, surveys found high levels of active trachoma across Libya, particularly in southern communities. Early control efforts in the 1970s and 1980s began reducing transmission, but the disease persisted in pockets.

In 2017, Libya's Ministry of Health made trachoma elimination a national priority. New surveys in 2022 covered six southern districts where the disease was suspected to linger. Health teams found infection rates had dropped below elimination thresholds in most areas, except for one district that needed additional surgical treatment for trichiasis, the painful eyelash condition.

A follow-up survey this year confirmed success. Libya now joins 27 other countries that have defeated trachoma, becoming the eighth in the Eastern Mediterranean Region to reach this milestone.

The victory required coordination between Libya's Ministry of Health, WHO, and international partners like Sightsavers and the International Trachoma Initiative. Health workers expanded surgical care access, built capacity among eye health professionals, and maintained surveillance systems even when basic services were disrupted.

The Ripple Effect

Libya's success sends a powerful message to the 45 countries where trachoma still causes suffering. Neglected tropical diseases like trachoma affect one billion people globally, primarily in impoverished communities with limited access to clean water and sanitation.

When a country eliminates such a disease despite facing humanitarian crises and political instability, it proves that progress is possible anywhere. The achievement demonstrates what coordinated technical support and evidence-based programming can accomplish, even in the most difficult circumstances.

Nine countries achieved similar validations for neglected tropical diseases in 2025 alone, showing accelerating momentum toward global elimination goals. Each victory protects vulnerable communities and frees health systems to address other pressing needs.

Libya's health workers can now celebrate knowing their dedication has ensured that no Libyan child will go blind from trachoma again.